RT Journal Article
SR Electronic
T1 829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A927
OP A927
DO 10.1136/jitc-2023-SITC2023.0829
VO 11
IS Suppl 1
A1 Salameh, Ahmad
A1 Conti, Laura
A1 Bolli, Elisabetta
A1 Cossu, Chiara
A1 Iezzi, Manuela
A1 Blezinger, Paul
A1 Gagliardi, Christine
A1 Cavallo, Federica
A1 Barlow, James
A1 Curran, Michael
A1 Pericle, Federica
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A927.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.